Meanwhile, DNA repair defects due to BRCA1/2 mutation instigate immune signaling through the cGAS/STING pathway, and the inflammatory signaling provides both tumor-suppressive as well as tumor-promoting traits (52, 54). This evidence concerns the gene BRCA1 and neoplasm.